gadolinium dtpa has been researched along with Diabetic Nephropathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, M; High, WA; Jackson, BP; Lanzirotti, A; Punshon, T; Ranville, JF | 1 |
| Thomsen, HS | 1 |
3 other study(ies) available for gadolinium dtpa and Diabetic Nephropathies
| Article | Year |
|---|---|
Gadolinium deposition in nephrogenic systemic fibrosis: an examination of tissue using synchrotron x-ray fluorescence spectroscopy.
Topics: Aged; Aged, 80 and over; Contrast Media; Diabetic Nephropathies; Eccrine Glands; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic; Spectrometry, Fluorescence; Synchrotrons | 2010 |
[Nephrogenic systemic fibrosis or kidney failure--how great is the risk?].
Topics: Adult; Aged; Angiography; Contrast Media; Diabetic Nephropathies; Dose-Response Relationship, Drug; Female; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Dialysis; Risk; Risk Factors; Tomography, X-Ray Computed | 2010 |
Gadolinium-based contrast media may be nephrotoxic even at approved doses.
Topics: Aged; Contrast Media; Diabetic Nephropathies; Diagnosis, Differential; Dose-Response Relationship, Drug; Gadolinium; Gadolinium DTPA; Humans; Kidney Function Tests; Magnetic Resonance Angiography; Male; Renal Artery Obstruction; Renal Insufficiency | 2004 |